<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Astellas and Pantherna  Enter into a New Technology Evaluation Agreement for Research with Expanded Target Organ to Generate mRNA-Based Regenerative Medicine Programs Using Direct Reprogramming	</title>
	<atom:link href="https://www.pantherna-therapeutics.com/astellas-and-pantherna-enter-into-a-new-technology-evaluation-agreement-for-research-with-expanded-target-organ-to-generate-mrna-based-regenerative-medicine-programs-using-direct-reprogramming/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.pantherna-therapeutics.com/astellas-and-pantherna-enter-into-a-new-technology-evaluation-agreement-for-research-with-expanded-target-organ-to-generate-mrna-based-regenerative-medicine-programs-using-direct-reprogramming/</link>
	<description>We restore endothelial cell function.</description>
	<lastBuildDate>Mon, 30 Jan 2023 10:59:27 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.1</generator>
</channel>
</rss>
